17-15945274-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000676.4(ADORA2B):āc.26T>Cā(p.Leu9Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000853 in 1,511,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000676.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADORA2B | NM_000676.4 | c.26T>C | p.Leu9Pro | missense_variant | 1/2 | ENST00000304222.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADORA2B | ENST00000304222.3 | c.26T>C | p.Leu9Pro | missense_variant | 1/2 | 1 | NM_000676.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000529 AC: 7AN: 132444Hom.: 0 AF XY: 0.0000565 AC XY: 4AN XY: 70814
GnomAD4 exome AF: 0.0000802 AC: 109AN: 1359356Hom.: 0 Cov.: 31 AF XY: 0.0000914 AC XY: 61AN XY: 667296
GnomAD4 genome AF: 0.000132 AC: 20AN: 152080Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.26T>C (p.L9P) alteration is located in exon 1 (coding exon 1) of the ADORA2B gene. This alteration results from a T to C substitution at nucleotide position 26, causing the leucine (L) at amino acid position 9 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at